Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04395586

Enrollment

Registered

2020-05-20

Start date

2020-07-01

Completion date

2021-06-30

Last updated

2022-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Culture-proven Infection

Brief summary

The characteristics of patients as well as microbiologic profile of culture-proven infection will be studies in conjunction with clinical outcome within 28-days

Interventions

OTHERCulture

Culture

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

13 Years to No maximum

Healthy volunteers

Inclusion criteria

* Any individual aged ≥13 year old requested for him/her bacterial/fungal culture. * Able to provide a written informed consent.

Exclusion criteria

* Age \<13 years old. * Unable/unwilling to provide a written informed consent.

Design outcomes

Primary

Measure	Time frame	Description
Mortality	28 days	All-cause and disease specific mortality

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026